Frontiers in Medicine (Mar 2022)

Posterior Reversible Encephalopathy Syndrome After Self-Medication With an Oral Decongestant: A Case Report

  • Yoann Zerbib,
  • Louis Gibert,
  • Youssef Bennis,
  • Youssef Bennis,
  • Kamel Masmoudi,
  • Julien Maizel,
  • Julien Maizel,
  • Clément Brault

DOI
https://doi.org/10.3389/fmed.2022.837324
Journal volume & issue
Vol. 9

Abstract

Read online

IntroductionPosterior reversible encephalopathy syndrome (PRES) is a rare neurological disorder caused by the dysregulation of cerebral perfusion.Case PresentationWe report on a 18-year-old female patient with a history of end-stage renal disease and thrice weekly hemodialysis. She was admitted to the emergency department with mental confusion, blurred vision, headaches, and vomiting, following self-medication with an oral decongestant containing pseudoephedrine. We observed hypointense lesions with T1-weighted MRI and hyperintense areas with T2-weighted and fluid-attenuated inversion recovery MRI sequences. The lack of diffusion restriction was consistent with a diagnosis of PRES. A concomitant Enterobacter cloacae hemodialysis catheter-bloodstream infection was also diagnosed. We hypothesize that both sepsis and inappropriate self-medication with oral pseudoephedrine contributed to hypertension, endothelial dysfunction, and vasogenic edema. The patient received intensive care and made a full recovery.DiscussionPRES is a life-threatening condition that requires intensive care. Identification of the etiology is the keystone of medical care. Inappropriate self-medication with an oral decongestant might trigger PRES - highlighting the importance of patient education.

Keywords